Heat Shock Proteins and Diabetes

Canadian Journal of Diabetes

Volumn 40, Issue 6, 2016, Pages 594-602

  Zilaee, Marzie ^a   Shirali, Saeed ^a  

^a AHVAZ JUNDISHAPUR UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

diabetes; glycation; heat shock protein; inflammation; oxidative stress

Indexed keywords

AUTOANTIBODY; CHAPERONE; HEAT SHOCK PROTEIN; PROTEIN ANTIBODY;

AGING; APOPTOSIS; ATHEROSCLEROSIS; CHRONIC DISEASE; DIABETES MELLITUS; DIABETIC ANGIOPATHY; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; DISEASE COURSE; ENVIRONMENTAL STRESS; FOOD INTAKE; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; INFLAMMATION; INSULIN DEPENDENT DIABETES MELLITUS; MEMBRANE FLUIDITY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; OXIDATIVE STRESS; PANCREAS ISLET BETA CELL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN GLYCOSYLATION; REVIEW; RISK; METABOLISM; PATHOPHYSIOLOGY; PROGNOSIS;

DIABETES MELLITUS; HEAT-SHOCK PROTEINS; HUMANS; PROGNOSIS;

EID: 84995944952     PISSN: 14992671     EISSN: 23523840     Source Type: Journal    
DOI: 10.1016/j.jcjd.2016.05.016     Document Type: Review

References (101)

1. 1 Whitham, M., Febbraio, M.A., HSP and diabetes. Heat shock proteins and whole body physiology. 2010, Springer, 3–18.
2. 2 Atalay, M., Oksala, N., Lappalainen, J., et al. Heat shock proteins in diabetes and wound healing. Curr Protein Pept Sci, 10, 2009, 85.
3. 3 Chen, Y., Voegeli, T.S., Liu, P.P., et al. Heat shock paradox and a new role of heat shock proteins and their receptors as anti-inflammation targets. Inflamm Allergy Drug Targets 6 (2007), 91–100.
4. 4 Rigano, R., Profumo, E., Buttari, B., et al. Heat shock proteins and autoimmunity in patients with carotid atherosclerosis. Ann N Y Acad Sci 1107 (2007), 1–10.
5. 5 Madrigal-Matute, J., Martin-Ventura, J.L., Blanco-Colio, L.M., et al. Heat-shock proteins in cardiovascular disease. Adv Clin Chem 54 (2011), 1–43.
6. 6 Chung, J., Nguyen, A.-K., Henstridge, D.C., et al. HSP72 protects against obesity-induced insulin resistance. Proc Natl Acad Sci U S A 105 (2008), 1739–1744.
7. 7 Mišur, I., Turk, Z., Substituted guanidine compounds as inhibitors of nonenzymatic glycation in vitro. Croatica Chem Acta 74 (2001), 455–465.
8. 8 Shirali, S., Zahra Bathaie, S., Nakhjavani, M., Effect of crocin on the insulin resistance and lipid profile of streptozotocin-induced diabetic rats. Phytother Res 27 (2013), 1042–1047.
9. 9 Shirali, S., Bathaei, S., Nakhjavani, M., Ashoori, M., Effects of saffron (Crocus Sativus L.) aqueous extract on serum biochemical factors in streptozotocin-induced diabetic rats., 28, 2012, 293–308.
10. 10 Bathaie, S., Mokarizade, N., Shirali, S., An overview of the mechanisms of plant ingredients in the treatment of diabetes mellitus., 11, 2012, 1–24.
11. 11 Toscano, C.M., As campanhas nacionais para detecção das doenças crônicas não-transmissíveis: diabetes e hipertensão arterial. Ciênc Saúde Coletiva 9 (2004), 885–895.
12. 12 Association, A.D., Diagnosis and classification of diabetes mellitus. Diabetes Care 36:Suppl. 1 (2013), S67–74.
13. 13 Chieri, R., Pivetta, O., Foglia, V., Altered ovulation pattern in experimental diabetes. Fertil Steril, 20, 1969, 661.
14. 14 Kirchick, H.J., Keyes, P.L., Frye, B.E., Etiology of an ovulation in the immature alloxan-diabetic rat treated with pregnant mare's serum gonadotropin: absence of the preovulatory luteinizing hormone surge. Endocrinology 102 (1978), 1867–1873.
15. 15 Daskalakis, G., Marinopoulos, S., Krielesi, V., et al. Placental pathology in women with gestational diabetes. Acta Obstet Gynecol Scand 87 (2008), 403–407.
16. 16 Wild, S., Roglic, G., Green, A., et al. Global prevalence of diabetes estimates for the year 2000 and projections for 2030. Diabetes Care 27 (2004), 1047–1053.
17. 17 Åkerfelt, M., Morimoto, R.I., Sistonen, L., Heat shock factors: Integrators of cell stress, development and lifespan. Nat Rev Mol Cell Biol 11 (2010), 545–555.
18. 18 Zilaee, M., Ferns, G., Ghayour-Mobarhan, M., Heat shock proteins and cardiovascular disease. Adv Clin Chem 64 (2013), 73–115.
19. 19 Ghayour-Mobarhan, M., Rahsepar, A., Tavallaie, S., et al. The potential role of heat shock proteins in cardiovascular disease: Evidence from in vitro and in vivo studies. Adv Clin Chem 48 (2009), 27–72.
20. 20 Ranford, J., Henderson, B., Chaperonins in disease: Mechanisms, models, and treatments. Mol Pathol, 55, 2002, 209.
21. 21 Morimoto, R.I., Cells in stress: Transcriptional activation of heat shock genes. Science, 259, 1993, 1409.
22. 22 Donnahoo, K.K., Shames, B.D., Harken, A.H., Meldrum, D.R., The role of tumor necrosis factor in renal ischemia-reperfusion injury. J Urol 162 (1999), 196–203.
23. 23 Shi, Y., Mosser, D.D., Morimoto, R.I., Molecular chaperones as HSF1-specific transcriptional repressors. Genes Dev 12 (1998), 654–666.
24. 24 Latchman, D.S., Heat shock proteins and cardiac protection. Cardiovasc Res 51 (2001), 637–646.
25. 25 Zhu, J., Quyyumi, A.A., Rott, D., et al. Antibodies to human heat-shock protein 60 are associated with the presence and severity of coronary artery disease: Evidence for an autoimmune component of atherogenesis. Circulation 103 (2001), 1071–1075.
26. 26 Ford, P.J., Seymourm, G.J., Yamazaki, K., Cardiovascular and oral disease interactions: What is the evidence?. Prim Dent Care 14 (2007), 59–66.
27. 27 Ritossa, F., Discovery of the heat shock response. Cell Stress Chaperones, 1, 1996, 97.
28. 28 Westerheide, S.D., Morimoto, R.I., Heat shock response modulators as therapeutic tools for diseases of protein conformation. J Biol Chem 280 (2005), 33097–33100.
29. 29 Tytell, M., Hooper, P.L., Heat shock proteins: new keys to the development of cytoprotective therapies. Emerg Therapeut Targ 5 (2001), 267–287.
30. 30 Shan, Y.-X., Yang, T.-L., Mestril, R., Wang, P.H., Hsp10 and Hsp60 suppress ubiquitination of insulin-like growth factor-1 receptor and augment insulin-like growth factor-1 receptor signaling in cardiac muscle: Implications on decreased myocardial protection in diabetic cardiomyopathy. J Biol Chem 278 (2003), 45492–45498.
31. 31 Strokov, I., Manukhina, E., Bakhtina, L.Y., et al. The function of endogenous protective systems in patients with insulin-dependent diabetes mellitus and polyneuropathy: Effect of antioxidant therapy. Bull Exp Biol Med 130 (2000), 986–990.
32. 32 Kurucz, I., Morva, Á., Vaag, A., et al. Decreased expression of heat shock protein 72 in skeletal muscle of patients with type 2 diabetes correlates with insulin resistance. Diabetes 51 (2002), 1102–1109.
33. 33 Patti, M.E., Butte, A.J., Crunkhorn, S., et al. Coordinated reduction of genes of oxidativlie metabolism in humans with insulin resistance and diabetes: Potential role of PGC1 and NRF1. Proc Natl Acad Sci U S A 100 (2003), 8466–8471.
34. 34 Bruce, C.R., Carey, A.L., Hawley, J.A., Febbraio, M.A., Intramuscular heat shock protein 72 and heme oxygenase-1 mrna are reduced in patients with type 2 diabetes: evidence that insulin resistance is associated with a disturbed antioxidant defense mechanism. Diabetes 52 (2003), 2338–2345.
35. 35 Ahmed, N., Advanced glycation end products-role in pathology of diabetic complications. Diabetes Res Clin Pract 67 (2005), 3–21.
36. 36 Jafarnejad, A., Bathaie, S., Nakhjavani, M., Hassan, M., Banasadegh, S., The improvement effect of L-Lys as a chemical chaperone on STZ-induced diabetic rats, protein structure and function. Diabetes Metab Res Rev 24 (2008), 64–73.
37. 37 Bathaie, S.Z., Jafarnejad, A., Hosseinkhani, S., Nakhjavani, M., The effect of hot-tub therapy on serum Hsp70 level and its benefit on diabetic rats: A preliminary report. Int J Hyperthermia 26 (2010), 577–585.
38. 38 Hooper, P.L., Balogh, G., Rivas, E., et al. The importance of the cellular stress response in the pathogenesis and treatment of type 2 diabetes. Cell Stress Chaperones 19 (2014), 447–464.
39. 39 Baynes, J.W., Role of oxidative stress in development of complications in diabetes. Diabetes 40 (1991), 405–412.
40. 40 Brownlee, M., Biochemistry and molecular cell biology of diabetic complications. Nature 414 (2001), 813–820.
41. 41 Atalay, M., Oksala, N.K., Laaksonen, D.E., et al. Exercise training modulates heat shock protein response in diabetic rats. J Appl Physiol 97 (2004), 605–611.
42. 42 Dandona, P., Thusu, K., Cook, S., et al. Oxidative damage to DNA in diabetes mellitus. Lancet 347 (1996), 444–445.
43. 43 Kaneto, H., Matsuoka, T.-A., Nakatani, Y., et al. Oxidative stress, ER stress, and the JNK pathway in type 2 diabetes. J Mol Med 83 (2005), 429–439.
44. 44 Li, M., Guo, D., Isales, C.M., et al. Sumo wrestling with type 1 diabetes. J Mol Med 83 (2005), 504–513.
45. 45 Hooper, P.L., Hooper, J.J., Loss of defense against stress: Diabetes and heat shock proteins. Diabetes Technol Ther 7 (2005), 204–208.
46. 46 Taylor, R., Causation of type 2 diabetes: the Gordian knot unravels. N Engl J Med 350 (2004), 639–640.
47. 47 Joyeux, M., Faure, P., Godin-Ribuot, D., et al. Heat stress fails to protect myocardium of streptozotocin-induced diabetic rats against infarction. Cardiovasc Res 43 (1999), 939–946.
48. 48 Wick, G., Knoflach, M., Xu, Q., Autoimmune and inflammatory mechanisms in atherosclerosis. Annu Rev Immunol 22 (2004), 361–403.
49. 49 Shamaei-Tousi, A., Stephens, J.W., Bin, R., et al. Association between plasma levels of heat shock protein 60 and cardiovascular disease in patients with diabetes mellitus. Eur Heart J 27 (2006), 1565–1570.
50. 50 Mandal, K., Jahangiri, M., Xu, Q., Autoimmunity to heat shock proteins in atherosclerosis. Autoimmun Rev 3 (2004), 31–37.
51. 51 Banecka-Majkutewicz, Z., Sawula, W., Kadzinski, L., et al. Homocysteine, heat shock proteins, genistein and vitamins in ischemic stroke: pathogenic and therapeutic implications. Acta Biochim Pol 59 (2012), 495–499.
52. 52 Lindsberg, P.J., Grau, A.J., Inflammation and infections as risk factors for ischemic stroke. Stroke 34 (2003), 2518–2532.
53. 53 Hooper, P.L., Hooper, P.L., Inflammation, heat shock proteins, and type 2 diabetes. Cell Stress Chaperones 14 (2009), 113–115.
54. 54 Bach, J.-F., Insulin-dependent diabetes mellitus as an autoimmune disease. Endocr Rev 15 (1994), 516–542.
55. 55 Elias, D., Markovits, D., Reshef, T., et al. Induction and therapy of autoimmune diabetes in the non-obese diabetic (NOD/Lt) mouse by a 65-kDa heat shock protein. Proc Natl Acad Sci U S A 87 (1990), 1576–1580.
56. 56 Szebeni, A., Prohászka, Z., Buzás, E., et al. Effects of vaccination with heat shock proteins on streptozotocin induced diabetes in histidine decarboxylase knockout mice. Inflamm Res 57 (2008), 178–182.
57. 57 Birk, O.S., Elias, D., Weiss, A.S., et al. NOD mouse diabetes: the ubiquitous mouse hsp60 is a β-cell target antigen of autoimmune T cells. J Autoimmun 9 (1996), 159–166.
58. 58 Abulafia-Lapid, R., Elias, D., Raz, I., et al. T cell proliferative responses of type 1 diabetes patients and healthy individuals to human hsp60 and its peptides. J Autoimmun 12 (1999), 121–129.
59. 59 Raz, I., Avron, A., Tamir, M., et al. Treatment of new-onset type 1 diabetes with peptide DiaPep277 is safe and associated with preserved beta-cell function: Extension of a randomized, double-blind, phase II trial. Diabetes Metab Res Rev 23 (2007), 292–298.
60. 60 Lee, M.-S., Chang, I., Kim, S., Death effectors of β-cell apoptosis in type 1 diabetes. Mol Genet Metab 83 (2004), 82–92.
61. 61 Mosser, D.D., Caron, A.W., Bourget, L., et al. Role of the human heat shock protein hsp70 in protection against stress-induced apoptosis. Mol Cell Biol 17 (1997), 5317–5327.
62. 62 Verheij, M., Bose, R., Lin, X.H., et al. Requirement for ceramide-initiated SAPK/JNK signalling in stress-induced apoptosis. 1996.
63. 63 Gabai, V.L., Meriin, A.B., Mosser, D.D., et al. Hsp70 prevents activation of stress kinases: a novel pathway of cellular thermotolerance. J Biol Chem 272 (1997), 18033–18037.
64. 64 Meldrum, K.K., Burnett, A.L., Meng, X., et al. Liposomal delivery of heat shock protein 72 into renal tubular cells blocks nuclear factor-kappaB activation, tumor necrosis factor-alpha production, and subsequent ischemia-induced apoptosis. Circ Res 92 (2003), 293–299.
65. 65 Bienemann, A., Lee, Y., Howarth, J., Uney, J., Hsp70 suppresses apoptosis in sympathetic neurones by preventing the activation of c-Jun. J Neurochem 104 (2008), 271–278.
66. 66 Patti, M., Butte, A., Cusi, K., et al. Analysis of differential gene expression in skeletal muscle from subjects with insulin resistance and type 2 diabetes. editors Diabetes, 50(Suppl. 2), 2001, A247.
67. 67 Flegal, K.M., Carroll, M.D., Ogden, C.L., Johnson, C.L., Prevalence and trends in obesity among US adults, 1999–2000. JAMA 288 (2002), 1723–1727.
68. 68 Hotamisligil, G.S., Inflammation and metabolic disorders. Nature 444 (2006), 860–867.
69. 69 Hotamisligil, G.S., Shargill, N.S., Spiegelman, B.M., Adipose expression of tumor necrosis factor-alpha: Direct role in obesity-linked insulin resistance. Science 259 (1993), 87–91.
70. 70 Uysal, K.T., Wiesbrock, S.M., Marino, M.W., Hotamisligil, G.S., Protection from obesity-induced insulin resistance in mice lacking TNF-α function. Nature 389 (1997), 610–614.
71. 71 Cancello, R., Henegar, C., Viguerie, N., et al. Reduction of macrophage infiltration and chemoattractant gene expression changes in white adipose tissue of morbidly obese subjects after surgery-induced weight loss. Diabetes 54 (2005), 2277–2286.
72. 72 Xu, H., Barnes, G.T., Yang, Q., et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest, 112, 2003, 1821.
73. 73 Landry, J., Bernier, D., Chrétien, P., et al. Synthesis and degradation of heat shock proteins during development and decay of thermotolerance. Cancer Res 42 (1982), 2457–2461.
74. 74 Park, H.S., Lee, J.S., Huh, S.H., et al. Hsp72 functions as a natural inhibitory protein of c-Jun N-terminal kinase. EMBO J 20 (2001), 446–456.
75. 75 Salminen, A., Paimela, T., Suuronen, T., Kaarniranta, K., Innate immunity meets with cellular stress at the IKK complex: regulation of the IKK complex by HSP70 and HSP90. Immunol Lett 117 (2008), 9–15.
76. 76 Weiss, Y.G., Bromberg, Z., Raj, N., et al. Enhanced heat shock protein 70 expression alters proteasomal degradation of IκB kinase in experimental acute respiratory distress syndrome. Crit Care Med 35 (2007), 2128–2138.
77. 77 Suzuki, K., Murtuza, B., Sammut, I.A., et al. Heat shock protein 72 enhances manganese superoxide dismutase activity during myocardial ischemia-reperfusion injury, associated with mitochondrial protection and apoptosis reduction. Circulation 106:Suppl. 1 (2002), S270–6.
78. 78 Chen, H.-W., Chen, S.-C., Tsai, J.-L., Yang, R.-C., Previous hyperthermic treatment increases mitochondria oxidative enzyme activity and exercise capacity in rats. Kaohsiung J Med Sci 15 (1999), 572–580.
79. 79 Hargitai, J., Lewis, H., Boros, I., et al. Bimoclomol, a heat shock protein co-inducer, acts by the prolonged activation of heat shock factor-1. Biochem Biophys Res Commun 307 (2003), 689–695.
80. 80 Radák, Z., Chung, H.Y., Naito, H., et al. Age-associated increase in oxidative stress and nuclear factor κB activation are attenuated in rat liver by regular exercise. FASEB J 18 (2004), 749–750.
81. 81 Heneka, M.T., Gavrilyuk, V., Landreth, G.E., et al. Noradrenergic depletion increases inflammatory responses in brain: effects on IκB and HSP70 expression. J Neurochem 85 (2003), 387–398.
82. 82 Sheikh-Hamad, D., Di Mari, J., Suki, W.N., et al. p38 kinase activity is essential for osmotic induction of mRNAs for HSP70 and transporter for organic solute betaine in Madin-Darby canine kidney cells. J Biol Chem 273 (1998), 1832–1837.
83. 83 Riordan, M., Sreedharan, R., Wang, S., et al. HSP70 binding modulates detachment of Na-K-ATPase following energy deprivation in renal epithelial cells. Am J Physiol Renal Physiol 288 (2005), F1236–42.
84. 84 Takenaka, I.M., Hightower, L.E., Transforming growth factor-beta 1 rapidly induces Hsp70 and Hsp90 molecular chaperones in cultured chicken embryo cells. J Cell Physiol 152 (1992), 568–577.
85. 85 Trautinger, F., Trautinger, I., Kindas-Mügge, I., et al. Human keratinocytes in vivo and in vitro constitutively express the 72-kD heat shock protein. J Invest Dermatol 101 (1993), 334–338.
86. 86 Jurivich, D.A., Sistonen, L., Kroes, R.A., Morimoto, R.I., Effect of sodium salicylate on the human heat shock response. Science 255 (1992), 1243–1245.
87. 87 Welsh, N., Margulis, B., Borg, L., et al. Differences in the expression of heat-shock proteins and antioxidant enzymes between human and rodent pancreatic islets: Implications for the pathogenesis of insulin-dependent diabetes mellitus. Mol Med, 1, 1995, 806.
88. 88 Hirakawa, T., Rokutan, K., Nikawa, T., Kishi, K., Geranylgeranylacetone induces heat shock proteins in cultured guinea pig gastric mucosal cells and rat gastric mucosa. Gastroenterology 111 (1996), 345–357.
89. 89 Ren, H., Musch, M.W., Kojima, K., et al. Short-chain fatty acids induce intestinal epithelial heat shock protein 25 expression in rats and IEC 18 cells. Gastroenterology 121 (2001), 631–639.
90. 90 Kim, D., Kim, S.-H., Li, G.C., Proteasome inhibitors MG132 and lactacystin hyperphosphorylate HSF1 and induce hsp70 and hsp27 expression. Biochem Biophys Res Commun 254 (1999), 264–268.
91. 91 Kawamura, H., Otsuka, T., Matsuno, H., et al. Endothelin-1 stimulates heat shock protein 27 induction in osteoblasts: involvement of p38 MAP kinase. Am J Physiol Endocrinol Metab 277 (1999), E1046–54.
92. 92 Westerheide, S.D., Bosman, J.D., Mbadugha, B.N., et al. Celastrols as inducers of the heat shock response and cytoprotection. J Biol Chem 279 (2004), 56053–56060.
93. 93 Turbyville, T.J., Wijeratne, E.K., Whitesell, L., Gunatilaka, A.L., The anticancer activity of the fungal metabolite terrecyclic acid A is associated with modulation of multiple cellular stress response pathways. Mol Cancer Ther 4 (2005), 1569–1576.
94. 94 Whitesell, L., Bagatell, R., Falsey, R., The stress response: implications for the clinical development of hsp90 inhibitors. Curr Cancer Drug Targ 3 (2003), 349–358.
95. 95 Bíró, K., Jednákovits, A., Kukorelli, T., et al. Bimoclomol (BRLP-42) ameliorates peripheral neuropathy in streptozotocin-induced diabetic rats. Brain Res Bull 44 (1997), 259–263.
96. 96 Rakonczay, Z., Iványi, B., Varga, I., et al. Nontoxic heat shock protein coinducer BRX-220 protects against acute pancreatitis in rats. Free Radic Biol Med 32 (2002), 1283–1292.
97. 97 Nanasi, P., Jednakovits, A., Multilateral in vivo and in vitro protective effects of the novel heat shock protein coinducer, bimoclomol: Results of preclinical studies. Cardiovasc Drug Rev 19 (2001), 133–151.
98. 98 Vigh, L., Literati, P.N., Horvath, I., et al. Bimoclomol: a nontoxic, hydroxylamine derivative with stress protein-inducing activity and cytoprotective effects. Nat Med 3 (1997), 1150–1154 Epub 10/23/1997.
99. 99 Török, Z., Tsvetkova, N.M., Balogh, G., et al. Heat shock protein coinducers with no effect on protein denaturation specifically modulate the membrane lipid phase. Proc Natl Acad Sci U S A 100 (2003), 3131–3136.
100. 100 Zilaee, M., Kermany, T., Tavalaee, S., et al. Barberry treatment reduces serum anti-heat shock protein 27 and 60 antibody titres and high-sensitivity c-reactive protein in patients with metabolic syndrome: A double-blind, randomized placebo-controlled trial. Phytother Res 28 (2014), 1211–1215.
101. 101 Shemshian, M., Mousavi, S.H., Norouzy, A., et al. Saffron in metabolic syndrome: its effects on antibody titers to heat-shock proteins 27, 60, 65 and 70. J Complement Integr Med 11 (2014), 43–49.